CardioWise, Inc. Named a Top-Ten Finalist in Best Cardiovascular Digital Diagnostic Category by UCSF Health Hub

Tuesday, October 8, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

CardioWise™ is commercializing patented, Cardiac Computed Tomography (CT) machine learning analysis software, SQuEEZ™, which produces a quantified image model of the human heart.

FAYETTEVILLE, Ark., Oct. 8, 2019 /PRNewswire-PRWeb/ -- The University of California San Francisco

(UCSF) Health Hub has selected CardioWise, Inc. a Digital Health Awards 1st Round (Top Ten) Finalist in its Best Cardiovascular Digital Diagnostic category. The goal of UCSF Digital Health Awards was to select companies that promote faster, better, more cost-effective healthcare by improving outcomes such as shorter hospital stays, reduced patient and insurer costs, faster cures, and happier doctors and patients. The awards are intended to showcase new technologies that are dramatically improving healthcare through innovative means, to benefit society and to reduce the onerous cost burden. Over 500 companies participated, representing thirteen categories, with over 100 judges.

As described by the Health Hub: "The goal of the UCSF Digital Health Awards is to ultimately help patients access amazing innovations by recognizing and awarding the great companies with the best in-market digital products and services. The live event, held in San Francisco on October 10, 2019, will be live-streamed and is the first of its kind patient and clinician oriented awards event."

"We are proud to have been chosen as a Top Ten Finalist in the Cardiovascular Digital Diagnostic category of the 2019 UCSF Digital Health Awards," said Jack Coats, CEO of CardioWise. "UCSF is recognized as an expert in digital health and has a superlative reputation, currently 7th in the US News national hospital rankings. For a startup company like CardioWise to have been chosen from over 500 applications by a team of prestigious judges, all organized by UCSF, is truly an honor and a tribute to our fine development team led by Geoffrey Dalbow, CardioWise CTO."

Top 10 companies in each category can be seen here: https://www.healthhubsf.org/awards/quarter-finalists

CardioWise™ is commercializing patented, non-invasive Cardiac CT analysis software that produces a quantified 4D image model of the human heart, called Stretch Quantifier for Endocardial Engraved Zones™ (SQuEEZ™). CardioWise heart analysis software combined with cardiac CT is a single diagnostic test that is able to provide quantitative analysis of the myocardium, arteries and valves with an unprecedented level of detail. It has the opportunity to become the new gold standard of care for heart health analysis. CardioWise™ is a VIC Technology Venture Development™ portfolio company.

 

SOURCE CardioWise, Inc.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store